Keertan Dheda focuses on Tuberculosis, Immunology, Mycobacterium tuberculosis, Internal medicine and Tuberculosis diagnosis. His Tuberculosis research is multidisciplinary, incorporating elements of Cohort study and Intensive care medicine. Keertan Dheda has included themes like Tuberculin and Latent tuberculosis in his Immunology study.
The Mycobacterium tuberculosis study combines topics in areas such as Rifampicin, Virology, T cell, Immunosuppression and Drug resistance. His study in Internal medicine is interdisciplinary in nature, drawing from both Moxifloxacin and Surgery. His Extensively drug-resistant tuberculosis research includes themes of Culture conversion and Epidemiology.
Keertan Dheda mostly deals with Tuberculosis, Immunology, Internal medicine, Mycobacterium tuberculosis and Sputum. His research integrates issues of Surgery, Drug resistance and Intensive care medicine in his study of Tuberculosis. His Drug resistance research is multidisciplinary, incorporating elements of Bedaquiline and Rifampicin.
His research investigates the link between Immunology and topics such as Latent tuberculosis that cross with problems in Tuberculin. His Internal medicine study combines topics in areas such as Gastroenterology and Lipoarabinomannan. His Mycobacterium tuberculosis research incorporates themes from Bronchoalveolar lavage, Interleukin 4 and Virology.
Keertan Dheda spends much of his time researching Tuberculosis, Internal medicine, Mycobacterium tuberculosis, Bedaquiline and Intensive care medicine. Keertan Dheda combines subjects such as Immunology and Drug resistance with his study of Tuberculosis. His Immunology study incorporates themes from Bacillus and Human lung.
His study focuses on the intersection of Internal medicine and fields such as Isoniazid with connections in the field of Rifampicin. The study incorporates disciplines such as Minimum inhibitory concentration, Whole genome sequencing, Host, Interleukin 4 and Computational biology in addition to Mycobacterium tuberculosis. His research in Intensive care medicine intersects with topics in Community-acquired pneumonia, MEDLINE, Disease, Cause of death and Extensively drug-resistant tuberculosis.
Keertan Dheda mainly investigates Tuberculosis, Internal medicine, Mycobacterium tuberculosis, Bedaquiline and Intensive care medicine. His Tuberculosis study frequently draws connections between related disciplines such as Drug resistance. In his research, Interim analysis and Cohort is intimately related to Vaccine efficacy, which falls under the overarching field of Internal medicine.
His studies deal with areas such as Effector, Intracellular, Cell biology and Gene knockdown as well as Mycobacterium tuberculosis. His Bedaquiline research focuses on subjects like Pharmacotherapy, which are linked to Pretomanid and Dosing. He has researched Intensive care medicine in several fields, including MEDLINE, Disease, Disease burden, Extensively drug-resistant tuberculosis and Prospective cohort study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Real-time RT-PCR normalisation; strategies and considerations
J Huggett;K Dheda;K Dheda;S Bustin;A Zumla.
Genes and Immunity (2005)
Validation of housekeeping genes for normalizing RNA expression in real-time PCR
Keertan Dheda;Jim F. Huggett;Stephen A. Bustin;Margaret A. Johnson.
Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis
Neel R Gandhi;Paul Nunn;Keertan Dheda;Keertan Dheda;H Simon Schaaf.
The Lancet (2010)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
M Voysey;Clemens Sac.;S A Madhi;L Y Weckx.
The Lancet (2021)
Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection
Madhukar Pai;Claudia M. Denkinger;Claudia M. Denkinger;Sandra V. Kik;Molebogeng X. Rangaka.
Clinical Microbiology Reviews (2014)
The implications of using an inappropriate reference gene for real-time reverse transcription PCR data normalization
K. Dheda;J.F. Huggett;J.S. Chang;L.U. Kim.
Analytical Biochemistry (2005)
Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis
Martina Sester;Giovanni Sotgiu;Christoph Lange;Claudia Giehl.
European Respiratory Journal (2011)
New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis.
Madhukar Pai;Shriprakash Kalantri;Keertan Dheda.
Expert Review of Molecular Diagnostics (2006)
Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial
Grant Theron;Lynn Zijenah;Duncan Chanda;Petra Clowes;Petra Clowes.
The Lancet (2014)
The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis
Keertan Dheda;Tawanda Gumbo;Gary Maartens;Kelly E. Dooley.
The Lancet Respiratory Medicine (2017)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: